Allogeneic adipose tissue‐derived stem cells ELIXCYTE(®) in chronic kidney disease: A phase I study assessing safety and clinical feasibility

The purpose of this phase I clinical trial is to assess the safety and tolerability of allogeneic adipose tissue‐derived stem cells (ADSCs) among chronic kidney disease (CKD) patients. 12 eligible CKD patients with an estimated glomerular filtration rate (eGFR) of 15–44 ml/min/1.73 m(2) received one...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Cai‐Mei, Chiu, I‐Jen, Chen, Yu‐Wei, Hsu, Yung‐Ho, Hung, Lie‐Yee, Wu, Mei‐Yi, Lin, Yuh‐Feng, Liao, Chia‐Te, Hung, Yi‐Pei, Tsai, Chia‐Chu, Cherng, Yih‐Giun, Wu, Mai‐Szu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097837/
https://www.ncbi.nlm.nih.gov/pubmed/35415928
http://dx.doi.org/10.1111/jcmm.17310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097837/
https://www.ncbi.nlm.nih.gov/pubmed/35415928
http://dx.doi.org/10.1111/jcmm.17310

Ejemplares similares